[A case of successful treatment using octreotide acetate for occlusive ileus in terminal stage cancer].
We report a 35-year-old female bearing ovarian cancer who was suffering from intestinal obstruction due to multiple recurrences. The treatment of 300 microg/day of octreotide acetate was started. The symptom of obstruction, such as vomiting and nausea, caused by intestinal obstruction was suddenly controlled and the quality of life was improved. Octreotide acetate can be applied for the management of intestinal obstruction caused by metastases at the terminal stage of cancer.
Yoshioka
Shinichi
S
Department of Surgery, Hyogo Prefectural Nishinomiya Hospital.
Tsujie
Masaki
M
Ebisui
Chikara
C
Okubo
Keita
K
Akitake
Hironori
H
Otsuka
Masahisa
M
Maekawa
Takayo
T
Hama
Naoki
N
Kashiwazaki
Masaki
M
Taniguchi
Masaaki
M
Konishi
Muneharu
M
Fujimoto
Takayoshi
T
D000328:Adult; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D045823:Ileus / Q000188:drug therapy* / Q000209:etiology; D009366:Neoplasm Seeding; D015282:Octreotide / Q000627:therapeutic use*; D010051:Ovarian Neoplasms / Q000473:pathology; D010534:Peritoneal Neoplasms / Q000150:complications / Q000556:secondary; D011788:Quality of Life; D013727:Terminal Care
D005765:Gastrointestinal Agents; D015282:Octreotide